Bayer recalls Lotrimin, Tinactin antifungal sprays citing carcinogen contamination
Whippany: Bayer has recently announced that the company is voluntarily recalling all unexpired Lotrimin AF and Tinactin spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2018 to September 2021, to the consumer level due to the presence of benzene in some samples of the products.
Benzene is not an ingredient in any of Bayer Consumer Health products.
"Bayer's decision to voluntarily recall these products is a precautionary measure and that the levels detected are not expected to cause adverse health consequences in consumers," the company said.
As per the risk statement released by the company," Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin. Depending on duration and level of exposure, it can result in cancers including leukemia, and blood cancer of the bone marrow and blood disorders which can be life-threatening. Benzene is found in the environment from natural sources and human activity. Humans around the world are exposed to it from multiple sources and pathways, including inhalation, through the skin, and orally. To date, Bayer has no known reports of adverse events related to this recall."
The affected Lotrimin and Tinactin spray products are over the counter antifungal products, sold individually or in combo packs. The impacted products are:
. Lotrimin Anti-Fungal (AF) Athlete's Foot Powder Spray
. Lotrimin Anti-Fungal Jock Itch (AFJI) Athlete's Foot Powder Spray
. Lotrimin Anti-Fungal (AF) Athlete's Foot Deodorant Powder Spray
. Lotrimin AF Athlete's Foot Liquid Spray
. Lotrimin AF Athlete's Foot Daily Prevention Deodorant Powder Spray
. Tinactin Jock Itch (JI) Powder Spray
. Tinactin Athlete's Foot Deodorant Powder Spray
. Tinactin Athlete's Foot Powder Spray
. Tinactin Athlete's Foot Liquid Spray
There are no issues of concern with Lotrimin/Tinactin creams, including Lotrimin Ultra, or any other Bayer products, it added.
The recalled products are all packaged in aerosol spray cans. The products were distributed in the U.S., Puerto Rico, Canada and Mexico through a variety of retail channels.
Consumers who have the products that are being recalled should stop using. Consumers should contact their physician or healthcare provider if they have any questions, concerns or have experienced any problems related to using these aerosol antifungal products.
"This recall is being conducted with the knowledge of the U.S. Food and Drug Administration," the release said
Read also: Bayer Finerenone gets USFDA approval to treat CKD associated with type 2 diabetes
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.